Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human TNNT2 Protein, N-His

Catalog #:   YHE44901 Specific References (1) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P45379
Protein length: Phe97-Lys298
Overview

Catalog No.

YHE44901

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Phe97-Lys298

Predicted molecular weight

27.07 kDa

Nature

Recombinant

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P45379

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Troponin T, cardiac muscle, TnTc, cTnT, TNNT2, Cardiac muscle troponin T

Note

For research use only.

Data Image
  • SDS-PAGE
    SDS PAGE for Recombinant Human TNNT2 Protein
  • Bioactivity
    Figure 6. Profiling of six cardiac biomarkers in clinical samples. (a) Acquired Raman signal distribution for all clinical samples, where the x-axis represents the disease groups and the y-axis depicts the normalized Raman intensity of each sample, calculated by dividing the detected intensities by those of the corresponding SERS barcodes. (b) Raman spectra and (c) heatmap from several representative samples of each sample, calculated by dividing the detected intensities by those of the corresponding SERS barcodes and a subsequent min−max scaling. LDA for the classification of (d) CRD and CAD and (e) CRD, CAD, and MI with the normalized Raman intensities of clinical samples. (f) ROC curve for the LDA model in classifying CAD versus CRD, evaluated using stratified 5-fold cross-validation. (g) Comparison of ELISA and Raman for analyzing the same clinical samples. The x-axis represents the clinical samples and the y-axis shows the concentration (ng/mL).
    Data sourced from citation (PMID: 40580100)
References

Multiplex Cardiac Biomarker Profiling for Precision Coronary Artery Disease Risk Assessment Using SERS with Cubic Core−Satellite Nanostructures. [YHE44901]

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human TNNT2 Protein, N-His [YHE44901]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2026 AntibodySystem All Rights Reserved.            All Products are for Research Use Only